Plasma levels of APRIL were lower in psychosis patients compared to healthy controls and significantly correlated with higher psychotic symptom load, though other studies have not found APRIL levels to differ (Crupi et al., 2010; Schmidt et al., 2019). This evidence concerns the gene TNFSF13 and psychotic disorder.